O'Neill Vincent

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$8.74M

Insider Activity of O'Neill Vincent

According to the SEC Form 4 filings, O'Neill Vincent, being in a position of

  1. See Remarks at BioXcel Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 6179 shares for $3,841,
    over all time since 2020-12-28, has bought 0 shares, and sold 186737 shares for $8.74M.

The largest sale of all time was on 2021-02-17 and amounted to 50000 shares of BioXcel Therapeutics, Inc. for $2.78M.

Biography of O'Neill Vincent

No biography is available at this moment.

2024-12-16SaleBioXcel Therapeutics, Inc.
BTAI
See Remarks
165
0.0003%
$0.35$58-14.76%
2024-10-03SaleBioXcel Therapeutics, Inc.
BTAI
See Remarks
5,556
0.014%
$0.55$3,056-1.4%
2024-09-16SaleBioXcel Therapeutics, Inc.
BTAI
See Remarks
138
0.0004%
$0.69$95-13.25%
2024-06-17SaleBioXcel Therapeutics, Inc.
BTAI
See Remarks
155
0.0004%
$1.28$199-53.95%
2024-04-04SaleBioXcel Therapeutics, Inc.
BTAI
See Remarks
165
0.0005%
$2.62$432-73.24%
2023-03-15SaleBioXcel Therapeutics, Inc.
BTAI
Chief Medical Officer
845
0.003%
$19.70$16,642-79.74%
2023-01-20SaleBioXcel Therapeutics, Inc.
BTAI
Chief Medical Officer
29,713
0.1028%
$30.00$891,390-66.53%
2021-02-17SaleBioXcel Therapeutics, Inc.
BTAI
Chief Medical Officer
50,000
0.2004%
$55.58$2.78M-47.29%
2021-01-19SaleBioXcel Therapeutics, Inc.
BTAI
Chief Medical Officer
50,000
0.2093%
$49.47$2.47M-36.19%
2020-12-28SaleBioXcel Therapeutics, Inc.
BTAI
Chief Medical Officer
50,000
0.2347%
$51.45$2.57M-37.57%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.